The Impact of Lymphatic Filariasis Mass Drug Administration Scaling Down on Soil-Transmitted Helminth Control in School-Age Children. Present Situation and Expected Impact from 2016 to 2020.
Identifieur interne : 000458 ( PubMed/Curation ); précédent : 000457; suivant : 000459The Impact of Lymphatic Filariasis Mass Drug Administration Scaling Down on Soil-Transmitted Helminth Control in School-Age Children. Present Situation and Expected Impact from 2016 to 2020.
Auteurs : Denise Mupfasoni [Suisse] ; Antonio Montresor [Suisse] ; Alexei Mikhailov [Suisse] ; Jonathan King [Suisse]Source :
- PLoS neglected tropical diseases [ 1935-2735 ] ; 2016.
Descripteurs français
- KwdFr :
- Afrique (épidémiologie), Albendazole (usage thérapeutique), Animaux, Antihelminthiques (administration et posologie), Antihelminthiques (usage thérapeutique), Antihelminthiques antinématodes (administration et posologie), Antihelminthiques antinématodes (usage thérapeutique), Asie (épidémiologie), Diéthylcarbamazine (usage thérapeutique), Enfant, Femelle, Filariose lymphatique (), Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (transmission), Filariose lymphatique (épidémiologie), Helminthiase (), Helminthiase (traitement médicamenteux), Humains, Ivermectine (usage thérapeutique), Mâle, Organisation mondiale de la santé, Programmes nationaux de santé, Prévalence, Sol (parasitologie), Établissements scolaires.
- MESH :
- administration et posologie : Antihelminthiques, Antihelminthiques antinématodes.
- parasitologie : Sol.
- traitement médicamenteux : Filariose lymphatique, Helminthiase.
- usage thérapeutique : Albendazole, Antihelminthiques, Antihelminthiques antinématodes, Diéthylcarbamazine, Filariose lymphatique, Ivermectine.
- épidémiologie : Afrique, Asie, Filariose lymphatique.
- Animaux, Enfant, Femelle, Filariose lymphatique, Helminthiase, Humains, Mâle, Organisation mondiale de la santé, Programmes nationaux de santé, Prévalence, Établissements scolaires.
English descriptors
- KwdEn :
- Africa (epidemiology), Albendazole (therapeutic use), Animals, Anthelmintics (administration & dosage), Anthelmintics (therapeutic use), Antinematodal Agents (administration & dosage), Antinematodal Agents (therapeutic use), Asia (epidemiology), Child, Diethylcarbamazine (therapeutic use), Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (prevention & control), Elephantiasis, Filarial (transmission), Female, Helminthiasis (drug therapy), Helminthiasis (prevention & control), Humans, Ivermectin (therapeutic use), Male, National Health Programs, Prevalence, Schools, Soil (parasitology), World Health Organization.
- MESH :
- chemical , administration & dosage : Anthelmintics, Antinematodal Agents.
- chemical , parasitology : Soil.
- chemical , therapeutic use : Albendazole, Anthelmintics, Antinematodal Agents, Diethylcarbamazine, Ivermectin.
- drug therapy : Elephantiasis, Filarial, Helminthiasis.
- epidemiology : Africa, Asia, Elephantiasis, Filarial.
- prevention & control : Elephantiasis, Filarial, Helminthiasis.
- transmission : Elephantiasis, Filarial.
- Animals, Child, Female, Humans, Male, National Health Programs, Prevalence, Schools, World Health Organization.
Abstract
Lymphatic filariasis (LF) and soil-transmitted-helminths (STH) are co-endemic in 58 countries which are mostly in Africa and Asia. Worldwide, 486 million school-age children are considered at risk of both diseases. In 2000, the World Health Organization (WHO) established the global programme to eliminate LF by 2020. Since then, the LF elimination programme has distributed ivermectin or diethylcarbamazine citrate (DEC) in combination with albendazole, thereby also treating STH. Consequently, many school-age children have been treated for STH through the LF programme. As treatment targets towards the 2020 LF elimination goal are achieved, many countries are implementing the transmission assessment survey (TAS) and, if the LF prevalence is estimated to be less than 1%, scaling down mass drug administration (MDA). We analysed the 2014 data on preventive chemotherapy (PC) reported from LF STH co-endemic countries and projected the year and location of TAS expected to be conducted between 2016 and 2020 to assess the impact of this scaling down on STH PC. Eighty percent of all co-endemic countries that have already stopped LF MDA nationally were able to establish STH PC through schools. It is estimated that 14% of the total number of children presently covered by the LF programme is at risk of not continuing to receive PC for STH. In order to achieve and maintain the WHO 2020 goal for STH control, there is an urgent need to establish and reinforce school-based deworming programmes in countries scaling-down national LF elimination programmes.
DOI: 10.1371/journal.pntd.0005202
PubMed: 27992424
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000458
Links to Exploration step
pubmed:27992424Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Impact of Lymphatic Filariasis Mass Drug Administration Scaling Down on Soil-Transmitted Helminth Control in School-Age Children. Present Situation and Expected Impact from 2016 to 2020.</title><author><name sortKey="Mupfasoni, Denise" sort="Mupfasoni, Denise" uniqKey="Mupfasoni D" first="Denise" last="Mupfasoni">Denise Mupfasoni</name><affiliation wicri:level="1"><nlm:affiliation>Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva</wicri:regionArea></affiliation></author><author><name sortKey="Montresor, Antonio" sort="Montresor, Antonio" uniqKey="Montresor A" first="Antonio" last="Montresor">Antonio Montresor</name><affiliation wicri:level="1"><nlm:affiliation>Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva</wicri:regionArea></affiliation></author><author><name sortKey="Mikhailov, Alexei" sort="Mikhailov, Alexei" uniqKey="Mikhailov A" first="Alexei" last="Mikhailov">Alexei Mikhailov</name><affiliation wicri:level="1"><nlm:affiliation>Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva</wicri:regionArea></affiliation></author><author><name sortKey="King, Jonathan" sort="King, Jonathan" uniqKey="King J" first="Jonathan" last="King">Jonathan King</name><affiliation wicri:level="1"><nlm:affiliation>Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27992424</idno><idno type="pmid">27992424</idno><idno type="doi">10.1371/journal.pntd.0005202</idno><idno type="wicri:Area/PubMed/Corpus">000458</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000458</idno><idno type="wicri:Area/PubMed/Curation">000458</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000458</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The Impact of Lymphatic Filariasis Mass Drug Administration Scaling Down on Soil-Transmitted Helminth Control in School-Age Children. Present Situation and Expected Impact from 2016 to 2020.</title><author><name sortKey="Mupfasoni, Denise" sort="Mupfasoni, Denise" uniqKey="Mupfasoni D" first="Denise" last="Mupfasoni">Denise Mupfasoni</name><affiliation wicri:level="1"><nlm:affiliation>Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva</wicri:regionArea></affiliation></author><author><name sortKey="Montresor, Antonio" sort="Montresor, Antonio" uniqKey="Montresor A" first="Antonio" last="Montresor">Antonio Montresor</name><affiliation wicri:level="1"><nlm:affiliation>Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva</wicri:regionArea></affiliation></author><author><name sortKey="Mikhailov, Alexei" sort="Mikhailov, Alexei" uniqKey="Mikhailov A" first="Alexei" last="Mikhailov">Alexei Mikhailov</name><affiliation wicri:level="1"><nlm:affiliation>Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva</wicri:regionArea></affiliation></author><author><name sortKey="King, Jonathan" sort="King, Jonathan" uniqKey="King J" first="Jonathan" last="King">Jonathan King</name><affiliation wicri:level="1"><nlm:affiliation>Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva</wicri:regionArea></affiliation></author></analytic><series><title level="j">PLoS neglected tropical diseases</title><idno type="eISSN">1935-2735</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Africa (epidemiology)</term><term>Albendazole (therapeutic use)</term><term>Animals</term><term>Anthelmintics (administration & dosage)</term><term>Anthelmintics (therapeutic use)</term><term>Antinematodal Agents (administration & dosage)</term><term>Antinematodal Agents (therapeutic use)</term><term>Asia (epidemiology)</term><term>Child</term><term>Diethylcarbamazine (therapeutic use)</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Elephantiasis, Filarial (transmission)</term><term>Female</term><term>Helminthiasis (drug therapy)</term><term>Helminthiasis (prevention & control)</term><term>Humans</term><term>Ivermectin (therapeutic use)</term><term>Male</term><term>National Health Programs</term><term>Prevalence</term><term>Schools</term><term>Soil (parasitology)</term><term>World Health Organization</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Afrique (épidémiologie)</term><term>Albendazole (usage thérapeutique)</term><term>Animaux</term><term>Antihelminthiques (administration et posologie)</term><term>Antihelminthiques (usage thérapeutique)</term><term>Antihelminthiques antinématodes (administration et posologie)</term><term>Antihelminthiques antinématodes (usage thérapeutique)</term><term>Asie (épidémiologie)</term><term>Diéthylcarbamazine (usage thérapeutique)</term><term>Enfant</term><term>Femelle</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Filariose lymphatique (transmission)</term><term>Filariose lymphatique (épidémiologie)</term><term>Helminthiase ()</term><term>Helminthiase (traitement médicamenteux)</term><term>Humains</term><term>Ivermectine (usage thérapeutique)</term><term>Mâle</term><term>Organisation mondiale de la santé</term><term>Programmes nationaux de santé</term><term>Prévalence</term><term>Sol (parasitologie)</term><term>Établissements scolaires</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anthelmintics</term><term>Antinematodal Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="parasitology" xml:lang="en"><term>Soil</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Albendazole</term><term>Anthelmintics</term><term>Antinematodal Agents</term><term>Diethylcarbamazine</term><term>Ivermectin</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antihelminthiques</term><term>Antihelminthiques antinématodes</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Helminthiasis</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Africa</term><term>Asia</term><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="parasitologie" xml:lang="fr"><term>Sol</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Helminthiasis</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term><term>Helminthiase</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Albendazole</term><term>Antihelminthiques</term><term>Antihelminthiques antinématodes</term><term>Diéthylcarbamazine</term><term>Filariose lymphatique</term><term>Ivermectine</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Afrique</term><term>Asie</term><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Child</term><term>Female</term><term>Humans</term><term>Male</term><term>National Health Programs</term><term>Prevalence</term><term>Schools</term><term>World Health Organization</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Enfant</term><term>Femelle</term><term>Filariose lymphatique</term><term>Helminthiase</term><term>Humains</term><term>Mâle</term><term>Organisation mondiale de la santé</term><term>Programmes nationaux de santé</term><term>Prévalence</term><term>Établissements scolaires</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphatic filariasis (LF) and soil-transmitted-helminths (STH) are co-endemic in 58 countries which are mostly in Africa and Asia. Worldwide, 486 million school-age children are considered at risk of both diseases. In 2000, the World Health Organization (WHO) established the global programme to eliminate LF by 2020. Since then, the LF elimination programme has distributed ivermectin or diethylcarbamazine citrate (DEC) in combination with albendazole, thereby also treating STH. Consequently, many school-age children have been treated for STH through the LF programme. As treatment targets towards the 2020 LF elimination goal are achieved, many countries are implementing the transmission assessment survey (TAS) and, if the LF prevalence is estimated to be less than 1%, scaling down mass drug administration (MDA). We analysed the 2014 data on preventive chemotherapy (PC) reported from LF STH co-endemic countries and projected the year and location of TAS expected to be conducted between 2016 and 2020 to assess the impact of this scaling down on STH PC. Eighty percent of all co-endemic countries that have already stopped LF MDA nationally were able to establish STH PC through schools. It is estimated that 14% of the total number of children presently covered by the LF programme is at risk of not continuing to receive PC for STH. In order to achieve and maintain the WHO 2020 goal for STH control, there is an urgent need to establish and reinforce school-based deworming programmes in countries scaling-down national LF elimination programmes.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27992424</PMID><DateCreated><Year>2016</Year><Month>12</Month><Day>19</Day></DateCreated><DateCompleted><Year>2017</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2017</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1935-2735</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>12</Issue><PubDate><Year>2016</Year><Month>Dec</Month></PubDate></JournalIssue><Title>PLoS neglected tropical diseases</Title><ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation></Journal><ArticleTitle>The Impact of Lymphatic Filariasis Mass Drug Administration Scaling Down on Soil-Transmitted Helminth Control in School-Age Children. Present Situation and Expected Impact from 2016 to 2020.</ArticleTitle><Pagination><MedlinePgn>e0005202</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0005202</ELocationID><Abstract><AbstractText>Lymphatic filariasis (LF) and soil-transmitted-helminths (STH) are co-endemic in 58 countries which are mostly in Africa and Asia. Worldwide, 486 million school-age children are considered at risk of both diseases. In 2000, the World Health Organization (WHO) established the global programme to eliminate LF by 2020. Since then, the LF elimination programme has distributed ivermectin or diethylcarbamazine citrate (DEC) in combination with albendazole, thereby also treating STH. Consequently, many school-age children have been treated for STH through the LF programme. As treatment targets towards the 2020 LF elimination goal are achieved, many countries are implementing the transmission assessment survey (TAS) and, if the LF prevalence is estimated to be less than 1%, scaling down mass drug administration (MDA). We analysed the 2014 data on preventive chemotherapy (PC) reported from LF STH co-endemic countries and projected the year and location of TAS expected to be conducted between 2016 and 2020 to assess the impact of this scaling down on STH PC. Eighty percent of all co-endemic countries that have already stopped LF MDA nationally were able to establish STH PC through schools. It is estimated that 14% of the total number of children presently covered by the LF programme is at risk of not continuing to receive PC for STH. In order to achieve and maintain the WHO 2020 goal for STH control, there is an urgent need to establish and reinforce school-based deworming programmes in countries scaling-down national LF elimination programmes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mupfasoni</LastName><ForeName>Denise</ForeName><Initials>D</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-8052-8272</Identifier><AffiliationInfo><Affiliation>Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montresor</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mikhailov</LastName><ForeName>Alexei</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Negl Trop Dis</MedlineTA><NlmUniqueID>101291488</NlmUniqueID><ISSNLinking>1935-2727</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000871">Anthelmintics</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000969">Antinematodal Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012987">Soil</NameOfSubstance></Chemical><Chemical><RegistryNumber>70288-86-7</RegistryNumber><NameOfSubstance UI="D007559">Ivermectin</NameOfSubstance></Chemical><Chemical><RegistryNumber>F4216019LN</RegistryNumber><NameOfSubstance UI="D015766">Albendazole</NameOfSubstance></Chemical><Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber><NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2012 Apr;106(4):215-22</RefSource><PMID Version="1">22357399</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2016 May 10;10(5):e0004707</RefSource><PMID Version="1">27163294</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2015 Sep 18;90(38):489-504</RefSource><PMID Version="1">26387149</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasit Vectors. 2014 Jan 23;7:46</RefSource><PMID Version="1">24450283</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2015 Dec 18;90(51-52):705-11</RefSource><PMID Version="1">26685391</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2012 Jan 13;87(2):17-27</RefSource><PMID Version="1">22242234</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2014 Apr;90(4):661-6</RefSource><PMID Version="1">24493672</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2015 Nov 19;9(11):e0004106</RefSource><PMID Version="1">26584484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2014 Feb 21;89(8):61-71</RefSource><PMID Version="1">24707511</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000349" MajorTopicYN="N">Africa</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015766" MajorTopicYN="N">Albendazole</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000871" MajorTopicYN="N">Anthelmintics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000969" MajorTopicYN="N">Antinematodal Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001208" MajorTopicYN="N">Asia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006373" MajorTopicYN="N">Helminthiasis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007559" MajorTopicYN="N">Ivermectin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009313" MajorTopicYN="Y">National Health Programs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012574" MajorTopicYN="N">Schools</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012987" MajorTopicYN="N">Soil</DescriptorName><QualifierName UI="Q000469" MajorTopicYN="Y">parasitology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014944" MajorTopicYN="N">World Health Organization</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>05</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27992424</ArticleId><ArticleId IdType="doi">10.1371/journal.pntd.0005202</ArticleId><ArticleId IdType="pii">PNTD-D-16-00914</ArticleId><ArticleId IdType="pmc">PMC5167227</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000458 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000458 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:27992424
|texte= The Impact of Lymphatic Filariasis Mass Drug Administration Scaling Down on Soil-Transmitted Helminth Control in School-Age Children. Present Situation and Expected Impact from 2016 to 2020.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:27992424" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |